ADUS Stock News 23.12 05/13/2014 14:44:05 Addus Homecare Corp

New Post Public Reply Private Reply Replies (0) Message Board

May 13, 2014 at 3:44 PM

Addus Homecare Corp (ADUS) 23.12 $ADUS

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday

Addus HomeCare posts net income from continuing operations of USD2.4m for Q1 2014
M2 - Fri May 02, 6:54AM CDT
Community services company Addus HomeCare (NasdaqGS:ADUS) announced on Thursday its net income from continuing operations of USD2.4m (USD0.21 per diluted share) for the first quarter ended 31 March 2014.

Addus HomeCare Reports First Quarter 2014 Results
PR Newswire - Thu May 01, 3:01PM CDT
Addus HomeCare Corporation (Nasdaq: ADUS), a comprehensive provider of home and community based services which are primarily social in nature and are provided in the home, focused on the dual eligible population, announced today its financial results for the first quarter ended March 31, 2014.

Moving Average Crossover: Great News for Addus (ADUS)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 6:15AM CDT
Moving Average Crossover: Great News for Addus (ADUS)?

Addus HomeCare (PAL) Crumbles: Stock Drops 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 8:15AM CDT
Addus HomeCare’s shares fell over 5% yesterday, breaking its one-month volatile trading range

Addus HomeCare Announces First Quarter 2014 Earnings Release and Conference Call
PR Newswire - Mon Apr 14, 3:00PM CDT
Addus HomeCare Corporation (Nasdaq:ADUS), a comprehensive provider of home and community based services focused primarily on the dual eligible population, announced today that it will release earnings for the first quarter ended March 31, 2014 on Thursday, May 1, 2014 after the market close.

Addus HomeCare Appoints Michael Earley to Board of Directors
PR Newswire - Tue Apr 01, 4:55PM CDT
Addus HomeCare Corporation (Nasdaq: ADUS), a comprehensive provider of home and community based services, which are primarily social in nature and provided in the home, and focused on the dual eligible population, today announced that Michael Earley has been appointed to its Board of Directors. Mr. Earley will serve on the Audit Committee.

Harwood Feffer LLP Announces Investigation of Addus HomeCare Corporation
PR Newswire - Thu Mar 27, 7:30PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Addus HomeCare Corporation ("Addus" or the "Company"

(NASDAQ: ADUS), concerning whether the board has breached its fiduciary duties to shareholders and/or whether it or the Company violated federal securities laws.

Attention Addus HomeCare Corporation Investors: Law Firm Investigates on Behalf of Shareholders
PR Newswire - Tue Mar 25, 5:37PM CDT
Shareholder rights law firm Robbins Arroyo LLP is investigating potential violations of federal securities laws on behalf of investors of Addus HomeCare Corporation (NASDAQ: ADUS). Addus HomeCare provides home and community based services to older adults and younger disabled persons in the United States.

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Addus HomeCare Corporation
PR Newswire - Fri Mar 14, 9:00AM CDT
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Addus HomeCare Corporation ("Addus HomeCare" or the "Company"

(NasdaqGS: ADUS -News). Such investors are advised to contact Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Addus HomeCare Corporation -- ADUS
PR Newswire - Thu Mar 13, 11:55AM CDT
Pomerantz LLP is investigating claims on behalf of investors of Addus HomeCare Corporation ("Addus HomeCare" or the "Company"

(NasdaqGS: ADUS) (CUSIP: 006739106). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.

Addus HomeCare announces 33.9% decline in operating income for Q4 2013
M2 - Thu Mar 13, 5:21AM CDT
Home service company Addus HomeCare (NasdaqGS:ADUS) stated on Wednesday its operating income from continuing operations of USD3.5m, or 5.0% of revenue, for the fourth quarter ended 31 December 2013.

Addus HomeCare Reports Fourth Quarter 2013 Results
PR Newswire - Wed Mar 12, 3:00PM CDT
Addus HomeCare Corporation (Nasdaq: ADUS), a comprehensive provider of home and community based services, which are primarily social in nature and provided in the home, and focused on the dual eligible population, announced today its financial results for the fourth quarter and year ended December 31, 2013.

5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 11, 11:27AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Addus HomeCare Announces Fourth Quarter 2013 Earnings Release and Conference Call
PR Newswire - Tue Feb 25, 11:30AM CST
Addus HomeCare Corporation (Nasdaq: ADUS), a comprehensive provider of home and community based services focused primarily on the dual eligible population, announced today that it will release earnings for the fourth quarter ended December 31, 2013 on Wednesday, March 12, 2014 after the market closes.

Saddle Creek Takes CNG Cross-Country
PR Newswire - Thu Feb 13, 3:30PM CST
(MindShare Strategies Media Services) This weekend, Saddle Creek Logistics Services will embark on "The Great American Green Ride," the first cross-country trip with a for-hire, compressed natural gas (CNG) truck.

DaVita Healthcare Beats on Q4 Earnings & Revs, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 10:20AM CST
DaVita HealthCare reported fourth-quarter 2013 net operating earnings of 99 cents per share, beating the Zacks Consensus Estimate by a penny

Quest Diagnostics Raised to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 2:10PM CST
On Feb 7, we upgraded Quest Diagnostics to Neutral following a decent fourth-quarter 2013.

CVS Caremark Beats on Q4 Earnings & Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 1:24PM CST
CVS Caremark reported third-quarter 2013 adjusted EPS of $1.12.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...